Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Atossa Genetics Inc (ATOS)

$1.67 0.02 (1.18%)

17:45 EDT ATOS Stock Quote Delayed 15 Minutes

Volume:

Previous Close $1.67

Market Cap 4.43M

PE Ratio -0.27

EPS -6.231901

Volume (Avg. Vol.) 53,914

Day's Range 1.66 - 1.76

52-Week Range 0.80 - 7.39

Dividend & Yield N/A (N/A)

ATOS Stock Predictions, Articles, and Atossa Genetics Inc News

From InvestorPlace
From the Web

Atossa Genetics News: FDA Approval Sends ATOS Stock Skyrocketing

By William White, InvestorPlace Writer Mar 14, 2019

Atossa Genetics news about it getting approval from the U.S. Food and Drug Administration for one its its drugs has its stock soaring.

Atossa Genetics reports positive Endoxifen data

From Seeking Alpha Sep 30, 2019

Atossa Genetics (NASDAQ:ATOS) is up 2% premarket on announcing preliminary results from its Phase 1 study of its modified-release tablet form of oral Endoxifen. All objectives were successfully met. N

18 Healthcare Stocks Moving In Monday's Pre-Market Session

From Benzinga Sep 30, 2019

Gainers Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) shares increased by 38.2% to $27.91 during Monday's pre-market session. The market cap seems to be at $560.4 million. The...

32 Healthcare Stocks Moving In Tuesday's Pre-Market Session

From Benzinga Sep 3, 2019

Gainers Cidara Therapeutics, Inc. (NASDAQ: CDTX) stock increased by 68.5% to $2.83 during Tuesday's pre-market session. The most recent rating by Oppenheimer, on June 06, is...

100 Biggest Movers From Yesterday

From Benzinga Aug 2, 2019

Gainers Myriad Genetics, Inc. (NASDAQ: MYGN) surged 54.5% to close at $45.01 on Thursday following news UnitedHealthcare issued a positive coverage decision for GeneSight. The...

72 Stocks Moving In Thursday's Mid-Day Session

From Benzinga Aug 1, 2019

Gainers Myriad Genetics, Inc. (NASDAQ: MYGN) jumped 43% to $41.79 following news UnitedHealthcare issued a positive coverage decision for GeneSight. SunPower Corporation (...

30 Stocks Moving In Monday's Pre-Market Session

From Benzinga Jul 15, 2019

Gainers Capricor Therapeutics Inc (NASDAQ: CAPR) rose 69.6% to $5.46 in pre-market trading after the company announced its interim analysis in the HOPE-2 trial to treat patients...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

B

Buy

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!